IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Deerfield Management Company, L.P.

Q1 2023 Holdings

Filed 2023-05-15 | 106 holdings | $4.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Viatris Inc(VTRS)COM92556V106$162.9M16,935,9973.6%
Natera IncNOTE 2.250% 5/0632307AB0$164.1M$101,042,0003.7%
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$171.7M10,355,0993.8%
Neurocrine Biosciences Inc(NBIX)COM64125C109$176.6M1,744,7143.9%
Glaukos CorpNOTE 2.750% 6/1377322AB8$336.2M$271,752,0007.5%
Nuvalent Inc(NUVL)COM670703107$521.6M19,991,02411.6%
PreviousPage 3 of 3